 |
|
 |
 |

Home > Company Index > Health Products & Services > Medical Instruments & Supplies > Charles River Laboratories International, Inc.
 |
Charles River Laboratories International, Inc. |
 |
 |
 |
NEWS FROM THE WIRES |
 |
Colombia's peso , stocks inch higher Aug 13 2001 02:42 PM PDT
Colombian supermarket chain Carulla plans bonds Aug 13 2001 11:08 AM PDT
Colombian stores Exito, Cadenalco to decide merger Aug 08 2001 04:08 PM PDT
Charles River beats Q2 estimates, sees strong 2001 Aug 02 2001 05:07 PM PDT
> More WIRE STORIES about this company
PROFILE |
 |
Charles River Laboratories International provides research products and services to the pharmaceutical and biotech industries to improve drug discovery and development. The firm mainly markets research models (rats and mice bred for preclinical experiments); this segment accounts for about 60% of sales. The company also provides biomedical products and services, including drug-safety assessment and testing. Charles River sells its products in more than 50 countries. Through a subsidiary, investment firm Credit Suisse First Boston (USA) (formerly Donaldson, Lufkin & Jenrette) owns about 30% of the company; Bausch & Lomb owns 5%. The company bought Genzyme Transgenics' contract research subsidiary, Primedica.
COMPETITION |
 |
ClinTrials Research Inc. (dossier)
Huntingdon Life Sciences Group plc (HTD)
MDS Inc. (MDZ)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 306.60
1-Yr. Sales Growth: 39.8%
Employees: 3,500
Revenue per employee: $87,600.00
KEY PEOPLE |
 |
James C. Foster
CEO
Thomas F. Ackerman
CFO
CONTACT INFO |
 |
251 Ballardvale St.
Wilmington, MA 01887
US
Phone: 978-658-6000
Fax: 978-658-7132
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |